Compound Summary
Compound Information
molsidomine
Compound Name: | molsidomine |
Compound CID: | 5353788 |
Synonyms: | molsidomine 25717-80-0 Corvaton morsydomine Molsidolat More... |
Iupac Name: | (1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate |
InChI: | InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3 |
InChIKey: | XLFWDASMENKTKL-UHFFFAOYSA-N |
Canonical Smiles: | CCOC(=NC1=C[N+](=NO1)N2CCOCC2)[O-] |
Isomeric Smiles: | CCO/C(=N/C1=C[N+](=NO1)N2CCOCC2)/[O-] |
Molecular Weight: | 242.23 |
Molecular Formula: | C9H14N4O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
molsidomine
Molecular Weight: | 242.23 |
Molecular Formula: | C9H14N4O4 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 17 |
Complexity: | 270 |
Synonyms
molsidomine
| molsidomine | molsidomine |
|---|---|
molsidomine |
25717-80-0 |
Corvaton |
morsydomine |
Molsidolat |
SIN-10 |
Motazomin |
Morial |
N-Ethoxycarbonyl-3-morpholinosydnonimine |
MLS000028573 |
UNII-D46583G77X |
CAS 276 |
(1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate |
SMR000058990 |
Sydnopharm |
N-(Ethoxycarbonyl)-3-(4-morpholino)sydnone imine |
Sydnone imine, N-(ethoxycarbonyl)-3-(4-morpholinyl)- |
MFCD00869301 |
D46583G77X |
N-Carboxy-3-morpholinosydnonimine ethyl ester |
NCGC00015661-02 |
N-Carboxy-3-morpholinosydnone imine ethyl ester |
CAS-25717-80-0 |
N-(Ethoxycarbonyl)-3-(4-morpholinyl)sydnone imine |
N-3-(4-morpholinyl)-5-oxadiazol-3-iumylcarbamic acid ethyl ester |
Sydnone imine, N-carboxy-3-morpholino-, ethyl ester |
DSSTox_CID_25171 |
DSSTox_RID_80721 |
DSSTox_GSID_45171 |
Molsidomina |
Molsidominum |
Covarsal |
Molsidominum INN-Latin |
Molsidomina INN-Spanish |
SR-05000001464 |
EINECS 247-207-4 |
BRN 3999414 |
ethyl (NZ)-N-(3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-ylidene)carbamate |
Molsidomine USAN:INN:BAN:JAN |
Prestwick_863 |
Opera_ID_238 |
Prestwick3_000547 |
Lopac-M-2901 |
SCHEMBL34019 |
BSPBio_000593 |
MLS001146942 |
MLS002153869 |
SPECTRUM1500673 |
Molsidomine (JAN/USAN/INN) |
BPBio1_000653 |
CHEMBL1256353 |
CHEMBL1329455 |
CHEMBL4059924 |
DTXSID0045171 |
BDBM39912 |
CHEBI:92623 |
cid_5353788 |
HMS501O05 |
HMS1569N15 |
HMS1921A16 |
HMS2089L03 |
HMS2092G20 |
HMS2096N15 |
HMS2232F20 |
HMS2235B12 |
HMS3262A12 |
HMS3649M16 |
HMS3713N15 |
HY-B1069 |
Molsidomine 1.0 mg/ml in Methanol |
Tox21_110192 |
Tox21_500725 |
BDBM50248123 |
CCG-40069 |
s4664 |
AKOS015843340 |
AKOS015900360 |
AKOS015962928 |
AKOS026749793 |
Tox21_110192_1 |
AC-7473 |
CCG-220547 |
CS-4625 |
DB09282 |
KS-5160 |
MCULE-1835289527 |
NSC 757398 |
SDCCGSBI-0050703.P005 |
NCGC00015661-01 |
NCGC00015661-03 |
NCGC00015661-04 |
NCGC00015661-05 |
NCGC00015661-06 |
NCGC00015661-07 |
NCGC00015661-08 |
NCGC00015661-09 |
NCGC00015661-10 |
NCGC00015661-12 |
NCGC00015661-16 |
NCGC00024136-03 |
NCGC00024136-04 |
NCGC00024136-05 |
NCGC00024136-06 |
NCGC00024136-07 |
NCGC00261410-01 |
SMR001233224 |
SBI-0050703.P004 |
AB00513859 |
EU-0100725 |
ST51015046 |
D01320 |
AB00052152_14 |
AB00513859-02 |
A817988 |
SR-05000001464-1 |
SR-05000001464-3 |
W-107222 |
ethoxy-N-(3-morpholin-4-yl(1,2,3-oxadiazol-5-yl))carboxamide |
(1E)-1-ethoxy-N-(3-morpholinooxadiazol-3-ium-5-yl)formimidate |
1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate |
(1E)-1-ethoxy-N-3-(4-morpholinyl)-5-oxadiazol-3-iumylmethanimidate |
(1E)-1-ethoxy-N-(3-morpholin-4-yl-1,2,3-oxadiazol-3-ium-5-yl)methanimidate |
(1E)-1-ethoxy-N-(3-morpholinooxadiazol-3-ium-5-yl)methanimidate;Molsidomine |
Experimental Data
molsidomine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 1 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
molsidomine
Statistics Data
molsidomine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 1 | 1 | 1 |
Statistics Data Visualization
molsidomine
